Throat Cancer Market – Overview:
The surge in throat cancer types is leading to the development of the market. Reports that review the pharmaceutical industry have been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities. The Throat Cancer Treatment Market Size is expected to advance with an increased CAGR in the forecast period.
Throat cancer can be described as the cancer of vocal cords, larynx, and other locations in the throat. The symptoms include a change in voice, cough, ear pain, sore throat, and issues in swallowing. Throat cancer comprises pharyngeal cancer and laryngeal cancer. Globally, in 2012, close to 157,000 cases of laryngeal cancer were diagnosed. In addition, the National Cancer Institute says that almost 1.1% of the adult population, at some point during their lifetime, is expected to be diagnosed with pharyngeal cancer and 0.4% with laryngeal cancer.
With the surge in the smoking population in emerging countries and the expansion of the aging population, the market is presumed to have a profitable run during the review period. But, the lack of targeted drugs for treating throat cancer could debilitate the growth rate of the market in the subsequent years
Competitive Analysis:
• Bristol-Myers Squibb
• Amgen Inc
• Engeneic Ltd
• Celgene Corporation
• F. Hoffmann-la Roche AG
• Novartis
• Pfizer Inc
• Eli Lilly and Company
• Merck & Co
• Teva Pharmaceutical Industries Ltd
Segmental Analysis:
• The segmentation based evaluation of the throat cancer market has been carried out on the basis of types, regions and treatment types.
• On the basis of types, the throat cancer market is segmented into laryngeal cancer and pharyngeal cancer.
• Based on the treatment types, the throat cancer market is segmented into radiation therapy, chemotherapy, surgery, and others.
• The regions included in the market for throat cancers comprises of Asia Pacific, the America, Europe, Africa and the Middle East.
Detailed Regional Analysis:
The regional review of the throat cancer market includes regions such as Asia Pacific, the America, Europe, Africa and the Middle East. The North American region controls the throat cancer market with the U.S. controlling the prime market share. The factors that are driving the throat cancer market are the expanding aging population, increasing demand for advanced cancer therapies, escalating government backing in the healthcare sector, and the development of cancer care amenities in budding countries. In the European region, the incidence of throat cancer cases is rising because of the boost in tobacco consumption, smoking, and alcohol consumption in these regions. The Asia Pacific region is anticipated to develop speedily with increasing countries such as China and India heading this market owing to the swiftly rising healthcare sector and large unmet requirements over the forecast period. The Middle East & African region market mainly, the African region is projected to observe reduced growth due to the deficit of knowledge in medical sector, and reduced development in the medical facilities in Middle East & African region will have restricted development in the market.